Latest / The Startup Exit Podcast with Fexingo: IPOs, Acquisitions, and Founder Liquidity Events
How RIVN and ARKG Signal a Shift in Growth Investing
Lucas and Luna examine the surprising recent rally in Rivian and ARK Genomic Revolution ETF, arguing that the market is rotating back toward long-duration growth stories after a brutal two-year correction. They discuss what the data says about institutional positioning, why the IPO pipeline is warming up, and how founders should think about timing their exits in this new regime. Specific numbers: RIVN up 6.5% in five days, ARKG up 9.1%. The hosts draw a line from these moves to the broader message for startups eyeing liquidity events. No hot takes, just the numbers and the logic.
#Rivian…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.